Alphabet Inc.

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 8, 2024), Alphabet Inc. reported 42 stock positions worth $1.8 billion. Its top holding was Gitlab Class A (GTLB) at 27.3% of the portfolio, followed by Arm Holdings PLC-ADR (ARM, 15.2%) and Revolution Medicines (RVMD, 10.5%). Compared with Q2 2024, it opened 1 new position, sold out of 1, added to 2 and reduced 2. The biggest buy was Freshworks Class A (FRSH, shares +31%) and the biggest sale Snowflake (SNOW, shares −79%).

Most Recent 13F
Q2 2026
Location
Mountain View, CA
CIK
0001652044
Portfolio Value
$1.8B (Q3 2024)
SEC Filing
0001652044-24-000123 ↗ filed Nov 8, 2024

Holdings Value

0$20.0B$40.0B$60.0B$80.0B$100.0B Q1 2024: $2.5B Q1 2024 Q2 2024: $2.0B Q2 2024 Q3 2024: $1.8B $1.8B Q3 2024 Q4 2024: $1.7B Q4 2024 Q1 2025: $1.6B Q1 2025 Q2 2025: $2.1B Q2 2025 Q3 2025: $2.4B Q3 2025 Q4 2025: $2.6B Q4 2025 Q1 2026: $4.0B Q1 2026 Q2 2026: $99.1B Q2 2026

Holdings 42 stocks · $1.8B
GTLB Gitlab Inc. Class A 27.30% 9,758,333 $502.9M No change
ARM Arm Holdings PLC-ADR 15.22% 1,960,784 $280.4M No change
RVMD Revolution Medicines Inc. 10.48% 4,256,175 $193.0M Reduce -19.8%
FRSH Freshworks Inc. Class A 10.10% 16,206,643 $186.1M Add +31.4%
CRWD CrowdStrike Holdings Inc. Class A 6.52% 427,895 $120.0M No change
PATH Uipath Inc. Class A 4.89% 7,034,337 $90.0M No change
TEM Tempus AI Inc. Class A 4.77% 1,551,102 $87.8M No change
PL Planet Labs PBC 3.87% 31,942,641 $71.2M No change
DXCM Dexcom Inc. 3.77% 1,036,937 $69.5M No change
VERV Verve Therapeutics Inc. 3.24% 12,349,086 $59.8M No change
PRME Prime Medicine Inc. 3.16% 15,062,498 $58.3M No change
SNOW Snowflake Inc. 0.71% 114,554 $13.2M Reduce -78.6%
SANA Sana Biotechnology Inc. 0.64% 2,812,500 $11.7M No change
RLAY Relay Therapeutics Inc. 0.60% 1,568,753 $11.1M No change
VERA Vera Therapeutics Inc. 0.58% 241,264 $10.7M No change
OSCR Oscar Health Inc. Class A 0.56% 481,988 $10.2M No change
LYEL Lyell Immunopharma Inc. 0.44% 5,865,125 $8.1M No change
BEAM Beam Therapeutics Inc. 0.43% 321,604 $7.9M No change
GLUE Monte Rosa Therapeutics Inc. 0.42% 1,464,015 $7.8M No change
DNTH Dianthus Therapeutics Inc. 0.31% 208,697 $5.7M No change
TCRX Tscan Therapeutics Inc. 0.29% 1,077,080 $5.4M No change
DM Desktop Metal Inc. Class A 0.28% 1,104,871 $5.2M No change
FHTX Foghorn Therapeutics Inc. 0.25% 500,901 $4.7M No change
BHILQ Benson Hill Inc. 0.17% 438,635 $3.2M Add +0.9%
AUTL Autolus Therapeutics PLC 0.14% 698,262 $2.5M No change
BRNS Barinthus Biotherapeutics PL 0.10% 1,513,644 $1.8M No change
TNYA Tenaya Therapeutics Inc. 0.10% 915,705 $1.8M No change
GUTS Fractyl Health Inc. 0.09% 662,584 $1.7M No change
EXAS Exact Sciences Corp. 0.09% 23,205 $1.6M No change
KRON Kronos Bio Inc. 0.08% 1,438,232 $1.4M No change
TSHA Taysha Gene Therapies Inc. 0.07% 640,882 $1.3M No change
SPRO Spero Therapeutics Inc. 0.06% 889,979 $1.2M No change
RAPT THERAPEUTICS INC 0.06% 540,270 $1.1M No change
HYPR Hyperfine Inc. 0.05% 898,720 $971K No change
RANI Rani Therapeutics Holdings Class A 0.05% 448,492 $969K No change
WGS Genedx Holdings Corp. 0.05% 22,711 $964K New
ALEC Alector Inc. 0.04% 175,866 $820K No change
QUINCE THERAPEUTICS INC 0.01% 189,122 $148K No change
RGEN Repligen Corp. 0.00% 383 $57K No change
FULC Fulcrum Therapeutics Inc. 0.00% 14,262 $51K No change
HLTHQ Cue Health Inc. 0.00% 27,000 $0 No change
NVTAQ Invitae Corp. 0.00% 235,606 $0 No change

Portfolio Sells Q2 2024 → Q3 2024
SNOW Snowflake Inc. Reduce -78.6% 0.71% −2.95
ILMN Illumina Inc. Sold out 0.00% −0.28
RVMD Revolution Medicines Inc. Reduce -19.8% 10.48% +0.05

Portfolio Buys Q2 2024 → Q3 2024
FRSH Freshworks Inc. Class A Add +31.4% 10.10% +2.17
BHILQ Benson Hill Inc. Add +0.9% 0.17% +0.05
WGS Genedx Holdings Corp. New 0.05% +0.05

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 28$99.1BSPCX, PL, ASTS, CME, ARM
Q1 2026 26$4.0BCME, PL, ASTS, RVMD, ARM
Q4 2025 29$2.6BASTS, PL, RVMD, ARM, FRSH
Q3 2025 37$2.4BASTS, PL, ARM, MTSR, RVMD
Q2 2025 36$2.1BASTS, ARM, FRSH, PL, RVMD
Q1 2025 40$1.6BFRSH, ARM, ASTS, RVMD, MTSR
Q4 2024 40$1.7BGTLB, FRSH, ARM, RVMD, CRWD
Q3 2024 42$1.8BGTLB, ARM, RVMD, FRSH, CRWD
Q2 2024 42$2.0BGTLB, ARM, RVMD, CRWD, FRSH
Q1 2024 43$2.5BGTLB, CRWD, DXCM, ARM, FRSH